Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 19;16(3):e0248284.
doi: 10.1371/journal.pone.0248284. eCollection 2021.

Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma

Affiliations

Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma

Przemyslaw Zabel et al. PLoS One. .

Abstract

Purpose: Assessment and a direct comparison of retinal vessel density with the thickness of inner retinal layer (IRL) and outer retinal layer (ORL) in the same regions of the macula in subjects with Alzheimer's disease (AD) and primary open-angle glaucoma (POAG).

Methods: We analyzed data from 48 eyes of healthy control (HC) participants, 71 eyes with POAG, and 49 eyes of AD patients. Ophthalmic examination included optical coherence tomography (OCT) imaging to measure IRL and ORL thickness and OCT angiography (OCTA) in the same region for the imaging of vessel density in the superficial vascular plexus (SVP) and deep vascular plexus (DVP) of the retina. A direct comparison of vessel density and retinal layers thickness, which different dynamic ranges, was obtained by normalizing values as percentage losses.

Results: Patients with AD presented significantly greater losses of vascular density in the DVP and ORL thickness compared to POAG (p <0.001), but percentage losses of vessel density in SVP and IRL thickness were considerable in POAG compared to AD eyes (p<0.001). Positive associations among presence of AD were observed primarily in outer retina where a 1% decrease of ORL thickness was associated with about 24-29% increase in odds of the presence of AD. According to OCTA measurements, a 1% decrease of vessel density in DVP was positively associated with a 4-9% increase in odds of the presence of AD. In POAG positive associations among presence of disease were observed only in inner retina where 1% loss of IRL thickness and a 1% loss of vessel density in the SVP were positively associated with a 13-23% increase in risk of presence of the disease.

Conclusions: Analysis of ORL thickness and vessel density in DVP could potentially improve diagnostic capabilities and may provide a valuable approach for predicting of AD.

PubMed Disclaimer

Conflict of interest statement

The authors have read the journal’s policy and have the following competing interest: RK is a paid employee of Sue Ryder Home leading by Pallmed Ltd (https://www.sueryder.org/). There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Representative optical coherence tomography image of an eye in a patient with Alzheimer’s disease.
Cross-sectional image along the horizontal meridian showing the segmentation boundaries of the inner retinal layer (IRL) and outer retinal layer (ORL) (green lines).
Fig 2
Fig 2. Scatterplots illustrating the correlation between percentage loss of retinal layers thickness and vessel density with linear regression curves in Alzheimer’s disease and primary open-angle glaucoma eyes.

Similar articles

Cited by

References

    1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387–403. 10.1016/S0140-6736(06)69113-7 - DOI - PubMed
    1. Jack CR, Bennett DA, Blennow K, et al.. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s and Dementia. 2018;14:535–62. 10.1016/j.jalz.2018.02.018 - DOI - PMC - PubMed
    1. Lee JC, Kim SJ, Hong S, Kim YS. Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Experimental and Molecular Medicine. 2019;51. 10.1038/s12276-019-0250-2 - DOI - PMC - PubMed
    1. Khan TK, Alkon DL. Alzheimer’s Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy. Journal of Alzheimer’s Disease. 2015;46:817–36. 10.3233/JAD-150238 - DOI - PubMed
    1. London A, Benhar I, Schwartz M. The retina as a window to the brain—From eye research to CNS disorders. Nature Reviews Neurology. 2013;9:44–53. 10.1038/nrneurol.2012.227 - DOI - PubMed

Publication types